Understanding the structure of tau proteins linked to Alzheimer's and related diseases
Structural analysis of tau associated with parenchymal and vascular prion protein amyloidosis
This study is looking at how tau proteins in the brain clump together and cause problems in diseases like Alzheimer's, with the goal of finding new ways to diagnose and treat these conditions for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11081779 on NIH RePORTER |
What this research studies
This research investigates the atomic structures of tau proteins that aggregate in the brain and contribute to neurodegenerative diseases like Alzheimer's. Using advanced techniques such as cryo-electron microscopy, the team aims to uncover how these tau aggregates form and their role in diseases characterized by abnormal protein deposits. The project also explores the effects of various modifications on tau proteins and how they influence disease progression. By understanding these mechanisms, the research seeks to pave the way for new diagnostic and therapeutic strategies for patients affected by these conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related tauopathies, particularly those with specific genetic mutations linked to tau aggregation.
Not a fit: Patients with neurodegenerative diseases not associated with tau protein aggregation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for Alzheimer's disease and related neurodegenerative disorders.
How similar studies have performed: Previous research has shown promising results in understanding tau protein structures and their implications in neurodegenerative diseases, indicating a strong foundation for this ongoing investigation.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Vidal, Ruben — Indiana University Indianapolis
- Study coordinator: Vidal, Ruben
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.